Case Report
Outpatient and Home Chemotherapy with Novel Local Control Strategies in Desmoplastic Small Round Cell Tumor
Table 1
Outpatient DSRCT chemotherapy: doses and schedule.
| Agent | Dose | Route | Comments |
| Preadjuvant phase of therapy (every 3 weeks 4 cycles) |
| Vincristine | 1.5 mg/m2 |
iv over 2–15 minutes | Max dose 2 mg; day 1 only | Etoposide | 150 mg/m2 |
iv over 1 hour | Day 1 only | Dexrazoxane | 750 mg/m2 |
iv over 15 minutes | Just before doxorubicin | Doxorubicin |
75 mg/m2 |
iv over 15 minutes | Day 1 only | Ifosfamide | 3 g/m2 |
iv daily 3 | Continuous infusion. Mix | + MESNA | 3 g/m2 |
iv daily 4 | with MESNA in 240–360 mL NS days 1, 2, 3. | MESNA only day 4 (portable pump as outpatient) |
| CHPP phase |
| Cisplatin | 100 mg/m2 | Intraperitoneal | As continuous peritoneal perfusion at 42°C 1.5 hr |
| Radio sensitization during RT |
| Temozolomide | 75 mg/m2 | po | Daily 5 2 weeks | Bevacizumab | 5 mg/kg | iv | q2 weeks 2 doses begin before RT |
| Pre-RT (2 cycles) and post-RT (10 cycles) |
| Temozolomide | 100 mg/m2 | po | Daily 5 each month | Irinotecan | 10 mg/m2 |
iv | Daily 5 2 weeks each month; may do as home infusions |
| Chronic continuation chemotherapy |
| Valproate | 500 mg/m2 | po | Daily; divide BID monitor level <100 | Rapamycin | 2 mg/m2 | po | Daily round to nearest mg | Cyclophosphamide | 25 mg | po | If >1.5 m2 may give 50 mg daily. Monitor cbc |
|
|